AlphAIalphai — Financial news for AI agents
yahoo.comAUG 313 min read$USNA

Reflecting On Personal Care Stocks’ Q2 Earnings: USANA (NYSE:USNA)

Nature's Sunshine (NYSE:USNA) reported $117M revenue, up 1.9% YoY, missing estimates. Herbalife (NYSE:HLF) reported $1.33B revenue, up 5.4%, beating estimates. Inter Parfums (NASDAQ:IPAR) reported $341M revenue, up 2.1%, beating estimates. All three stocks declined since earnings.

Original reporting
yahoo.com
Published Aug 31, 2026, 4:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 31, 2026, 5:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Reflecting On Personal Care Stocks’ Q2 Earnings: USANA (NYSE:USNA) — source image
Source · yahoo.com
Decision brief

The 30-second read

$USNANeutralMed
01

Why it matters

Earnings releases drive immediate price moves; mixed results suggest sector‑wide scrutiny.

02

Market read

Provides fresh earnings data for three listed personal‑care firms, useful for short‑term traders.

03

What to watch

Potential cost‑structure issues and competitive pressure not detailed in the article.

Relevance 8/10Novelty 7/10Timing: after‑hours

Background

The article reviews Q2 earnings of three personal‑care companies, noting revenue beats, EPS misses, and stock reactions.

Company-level read

Ticker impact

$USNANeutralLow confidence
Context

Title mentions USANA personal‑care Q2 earnings; article focuses on sector earnings.

Expected impact

No immediate price move indicated.

Evidence & confidence

Only a headline reference, no new numbers disclosed.

$HLFNeutralMedium confidence
Context

Herbalife posted Q2 revenue $1.33 B, beat sales estimates but missed EPS; stock flat after release.

Expected impact

Sideways trading likely.

Evidence & confidence

Revenue beat offsets EPS miss, resulting in flat price.

$IPARBearishMedium confidence
Context

Inter Parfums reported Q2 revenue $341 M, beating expectations; stock down 8.4% after earnings.

Expected impact

Potential further decline if margin concerns persist.

Evidence & confidence

Guidance miss and margin shortfall outweigh revenue beat.

Market effects

Sector

Personal‑care earnings highlight earnings volatility across the sector.

Regional

U.S. personal‑care stocks may see broader reassessment.

Global

Limited to investors tracking consumer‑goods earnings.

Counterpoint

What could challenge this read

Despite earnings misses, some investors may view the price drops as buying opportunities.

Key entities

  • company
    Nature's Sunshine

    Personal‑care supplement maker.

  • company
    Herbalife

    Nutrition and weight‑management products.

  • company
    Inter Parfums

    Fragrance and perfume licensor.

Read at source← All news

Related articles

AUG 31
$HLFHigh

Why Herbalife (HLF) Stock Is Nosediving

Herbalife (HLF) stock fell 13.2% after CEO Stephan Gratziani announced his departure, effective October 31, 2026. CFO John DeSimone will serve as interim CEO. The company's shares are down 14.2% YTD and 44.9% from their 52-week high. Argus Research previously upgraded HLF to 'Buy' with a $15 price target, citing expected revenue growth from new products.

financialcontent.com2 min
AUG 31
$HLFHigh

Why is Herbalife stock tumbling today?

Herbalife (HLF) stock fell 12.7% after announcing CEO Stephan Gratziani will step down by October 31, 2026, with CFO John DeSimone as interim CEO. The company reaffirmed its Q3 and full-year 2026 financial guidance, projecting net sales growth of 0.5% to 4.5% and adjusted EBITDA of $160M to $180M. Broader market declines and geopolitical tensions also contributed to the sell-off.

investing.com2 min
AUG 31
$HLFMedAI 8/10

Herbalife stock tumbles as CEO Gratziani to step down in 2026

Herbalife Ltd (NYSE: HLF) shares dropped 12.5% after announcing CEO Stephan Gratziani will step down in 2026. He will transition to a consultant role, and CFO John DeSimone will serve as interim CEO. The company reaffirmed its 2026 financial guidance, expecting YoY net sales growth and adjusted EBITDA of $670M-$690M for the full year.

investing.com2 min
AUG 12
$USNAMedAI 8/10

USANA (USNA) Q2 2026 Earnings Call Transcript

USANA (USNA) held its Q2 2026 earnings call. Management said Core Nutritional was stable, with Mainland China showing renewed strength. The company recorded a preliminary $29 million noncash goodwill impairment and $9 million income tax expense on a $19 million pretax loss. USANA ended the quarter with $169 million cash, zero debt, and $20 million free cash flow, and lowered its fiscal 2026 outlook due to HYA DTC marketing and Rise net sales.

yahoo.com6 min
AUG 11
$USNAMedAI 8/10

USANA Health Sciences Q2 Earnings Call Highlights

USANA Health Sciences (NYSE:USNA) reported Q2 updates including a $29 million preliminary non-cash goodwill impairment tied to its Hiya reporting unit and $9 million income tax expense on a $19 million pre-tax loss. Management cited about $30 million to $40 million top-line pressure and $4 million to $5 million margin pressure, plus a Rise packaging disruption. USANA ended with $169 million cash and no debt.

yahoo.com6 min